⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of SGN-ALPV in Advanced Solid Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of SGN-ALPV in Advanced Solid Tumors

Official Title: A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors

Study ID: NCT05229900

Interventions

SGN-ALPV

Study Description

Brief Summary: This study will test the safety of a drug called SGN-ALPV in participants with solid tumors. It will also study the side effects of this drug. A side effect is anything a drug does to your body besides treating your disease. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable). This study will have three parts. Parts A and B of the study will find out how much SGN-ALPV should be given to participants. Part C will use the dose and schedule found in Parts A and B to find out how safe SGN-ALPV is and if it works to treat solid tumor cancers.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Women's Cancer Care, Fresno, California, United States

Yale Cancer Center, New Haven, Connecticut, United States

Florida Cancer Specialists - Lake Nona, Wellington, Florida, United States

START Midwest, Grand Rapids, Michigan, United States

Oklahoma University at Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

START Mountain Region, West Valley City, Utah, United States

Virginia Cancer Specialists, Fairfax, Virginia, United States

Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

START Madrid-CIOCC_Hospital HM Sanchinarro, Madrid, Other, Spain

Karolinska University Hospital, Stockholm, Other, Sweden

The Royal Marsden NHS Foundation Trust (RM), London, Other, United Kingdom

Sarah Cannon Research Institute UK, London, Other, United Kingdom

Contact Details

Name: Suzanne McGoldrick, MD

Affiliation: Seagen Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: